Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00387049 · ClinicalTrials.gov registry record · NA
Anxiety Sensitivity Program for Smoking Cessation
A NA study, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00387049: Completed NA study, sponsored by University of Vermont.
NCT00387049 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00387049, a NA study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and test a smoking cessation intervention for persons who are specifically sensitive to anxiety and anxiety-related bodily sensations.
Interventions
- BEHAVIORAL Anxiety Sensitivity Program for Smoking Cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2005-01 |
| Est. Completion | 2010-04 |
| Phase | NA |
What the finished NCT00387049 record still lists
NCT00387049 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Anxiety Sensitivity Program for Smoking Cessation is the first listed.
NCT00387049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00387049 about?
NCT00387049 is a clinical study titled "Anxiety Sensitivity Program for Smoking Cessation". The purpose of this study is to develop and test a smoking cessation intervention for persons who are specifically sensitive to anxiety and anxiety-related bodily sensations.
What is the current status of trial NCT00387049?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2005-01. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00387049?
The interventions under investigation include: Anxiety Sensitivity Program for Smoking Cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00387049?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00387049's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia